Breastfeeding and body composition in children: will there ever be conclusive empirical evidence for a protective

Andreas Beyerlein1, Rüdiger von Kries

  • 1Institute of Social Paediatrics and Adolescent Medicine, Ludwig-Maximilians University of Munich, Munich, Germany. andreas.beyerlein@med.uni-muenchen.de

Insights

Breastfeeding may offer a protective effect against childhood overweight, but conclusive evidence is challenging to establish. Further research is needed to confirm the benefits of breastfeeding for long-term obesity prevention.

Area of Science:

  • Pediatrics
  • Public Health
  • Epidemiology

Background:

  • Global rise in childhood overweight necessitates obesity prevention strategies.
  • Early life exposures, including breastfeeding, are hypothesized to influence later obesity risk.
  • Human milk properties suggest potential protective mechanisms against overweight compared to formula feeding.

Purpose of the Study:

  • To review the epidemiologic literature on the relationship between breastfeeding and childhood overweight.
  • To synthesize evidence from observational and interventional studies.
  • To evaluate the potential of breastfeeding as a strategy for obesity prevention.

Main Methods:

  • Systematic review of epidemiologic literature.
  • Analysis of observational studies and meta-analyses.
  • Examination of evidence from limited interventional studies, including a randomized trial.

Main Results:

  • Several observational studies suggest a small protective effect of breastfeeding against childhood overweight.
  • Meta-analyses show mixed results, with some reporting significant protective effects and others finding no effect on mean body mass index (BMI).
  • Interventional studies are limited, and a randomized trial on breastfeeding promotion lacked statistical power.

Conclusions:

  • Breastfeeding may have protective priming effects against later overweight, but definitive proof is difficult to obtain.
  • Observational studies face challenges with confounding factors.
  • Interventional studies on breastfeeding promotion may lack sufficient statistical power to demonstrate effects.

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
Cause and Effect01:53

Cause and Effect

While variables are sometimes correlated because one does cause the other, it could also be that some other factor, a confounding variable, is actually causing the systematic movement in our variables of interest. For instance, as sales in ice cream increase, so does the overall rate of crime. Is it possible that indulging in your favorite flavor of ice cream could send you on a crime spree? Or, after committing crime do you think you might decide to treat yourself to a cone?
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...